Text Size

A A A

Search


 

 

ManagingAfib_banner

Managing Atrial Fibrillation
to Prevent Stroke

A Grand Rounds Program

Find and register for the program
at your hospital.

Register for this webinar

To learn more about holding a grand rounds
activity at your hospital, please contact
Valerie Siebert-Thomas
at vsiebert-thomas@stroke.org
or call 303-754-0926.

Program Overview
Atrial fibrillation (AF) affects more than two million people in the U.S. and is a serious risk factor for stroke. Despite evidence-based guidelines for managing AF and estimates that two-thirds of AF-related strokes can be avoided, serious gaps continue to exist between clinical knowledge and practice, leaving patients at risk for disabling strokes.

The Managing Atrial Fibrillation to Prevent Stroke grand rounds program will address AF and how it is diagnosed and treated; review prevalence of stroke in AF patients; discuss the use of appropriate tools to assess stroke risk; promote the use of current guidelines‐based strategies for managing AF for patients at different levels of stroke risk; share strategies for discussing AF and stroke risk more effectively with patients; and evaluate the emerging agents for stroke prevention in AF.

Goals and Learning Objectives
The goal of the Managing Atrial Fibrillation to Prevent Stroke grand rounds program is to improve the diagnosis and treatment of AF to prevent stroke by educating participants on the most current treatment guidelines and clinical research. Upon completion of this integrated CME initiative, participants will be able to:

  • Recognize the signs and symptoms of AF, such as abnormal rhythm, rate and/or near syncope as described by the patient or caregiver using nonmedical vernacular.
  • Select the appropriate diagnostic test(s) for the initial diagnosis of AF to determine underlying causes and severity of AF and to monitor improvement after AF treatment.
  • Demonstrate an understanding of the AF guidelines with regard to stroke risk.
  • Communicate essential information regarding AF and stroke risk to the patient.
  • Assess the risk of stroke in patients with AF by correctly calculating a CHADS2 risk score.
  • Determine appropriate anticoagulation based upon the stroke risk calculation, clinical guidelines and new scientific evidence.
  • Determine appropriate rhythm management and rate control strategies based upon clinical guidelines and new scientific evidence.
  • Distinguish which AF patients should be referred to a specialist.
  • Manage patients who have undergone an ablation procedure.

Target Audience
The target audience for the Managing Atrial Fibrillation to Prevent Stroke grand rounds program includes primary care clinicians and cardiologists practicing in and near stroke center hospitals, as well as hospital-based physicians, nurses and other healthcare professionals treating AF among at-risk populations.

Credit Designation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Heart Rhythm Society and National Stroke Association. The Heart Rhythm Society is accredited by the ACCME to provide continuing medical education for physicians and by the New York State Nurses Association to provide continuing education for nurses and nurse practitioners.

Continuing Medical Education (CME) for Physicians
Heart Rhythm Society designates this educational activity for a maximum 1.0 AMA PRA Category 1 credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education (CE) for Nurses
The Heart Rhythm Society is an approved provider of continuing nursing education by the New York State Nurses Association, which is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission of Accreditation. It has been assigned code 7M7R3X-PRV-09-30.

A maximum of 1.0 credit hours are available for this educational activity.

Content Developed by
Philip B. Gorelick, MD, MPH, FACP

Associate Professor and Head of Neurology and Rehabilitation
University of Illinois College of Medicine
Director, Stroke Research
Department of Neurology
University of Illinois
Chicago, Illinois


Jonathan L. Halperin, MD

Robert and Harriet Heilbrunn Professor of Medicine
Mount Sinai School of Medicine
Director of Clinical Cardiology Services
Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Medical Center
New York, New York

Disclosure of Faculty’s Commercial Relationship(s)
It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities are required to disclose any real or apparent conflict of interest related to the content of their presentations and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The Heart Rhythm Society implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Detailed disclosure information will be available prior to the activity and in the activity slides.

Click here to register for a program at your hospital.

Register for this webinar

This activity is supported by educational grants from the following companies:
Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC and Bristol-Myers Squibb and Pfizer, Inc.

Get Involved

Stroke and You

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org